![]() |
市场调查报告书
商品编码
1949460
电疗系统市场 - 全球产业规模、份额、趋势、机会及预测(按技术、应用、疗法、最终用户、地区和竞争格局划分),2021-2031年Electrotherapy System Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Technology, By Application, By Therapy, By End user, By Region & Competition, 2021-2031F |
||||||
全球电疗系统市场预计将从 2025 年的 12.8 亿美元成长到 2031 年的 18.8 亿美元,复合年增长率为 6.62%。
这些医疗系统利用电能刺激神经和肌肉,进而促进疼痛管理、神经肌肉再教育和组织修復。推动这一增长的关键因素包括慢性肌肉骨骼疾病患病率的上升以及全球老龄化人口的增长,这需要持续的物理復健。此外,市场也受益于向非侵入性和非药物疗法的显着转变,这主要是由于临床上迫切需要减少慢性疼痛患者的鸦片类药物成瘾。
| 市场概览 | |
|---|---|
| 预测期 | 2027-2031 |
| 市场规模:2025年 | 12.8亿美元 |
| 市场规模:2031年 | 18.8亿美元 |
| 复合年增长率:2026-2031年 | 6.62% |
| 成长最快的细分市场 | 经皮电刺激(TENS) |
| 最大的市场 | 北美洲 |
儘管存在这些积极因素,但市场扩张仍面临一个重大障碍:合格的復健专业短缺,无法提供这些治疗。人才短缺限制了诊所的容量,进而抑制了对新设备的需求。根据美国物理治疗协会 (APTA) 的数据,预计到 2024 年,全国门诊物理治疗诊所的空缺率将达到 9.5%,这凸显了劳动力短缺问题,直接阻碍了电疗系统的普及和广泛应用。
携带式和穿戴式电疗设备的科技进步正成为市场成长的主要驱动力,从根本上改变了患者获得疼痛管理的方式。紧凑易用的系统的出现,使得患者可以在家中有效地进行自我电刺激治疗,从而减少了频繁就诊的需要。这种向居家医疗的转变得益于商业性对新一代系统的强劲需求。例如,Zynex公司在2024年10月发布的2024年第三季财报中指出,其设备订单年增13%,显示市场对医用级非侵入性治疗方案有着浓厚的兴趣。这些创新不仅提高了患者的便利性,也有助于提高治疗的持续依从性,而这正是长期復原成功的关键因素。
慢性疼痛和肌肉骨骼疾病发生率的上升进一步推动了电疗作为一种主要的非药物治疗选择的应用。随着全球退化性疾病和文明病负担的加重,医疗保健提供者越来越重视无鸦片类治疗方法,以最大限度地降低持续疼痛管理中的成瘾风险。根据美国疾病管制与预防中心 (CDC) 于 2024 年 11 月发布的《2023 年美国成年人慢性疼痛和高影响慢性疼痛》报告,约 24.3% 的成年人患有慢性疼痛,这表明有大量患者需要有效的管理方案。这种日益增长的临床需求在全球范围内普遍存在,国际疼痛研究协会 (IASP) 指出,到 2024 年,“全球五分之一的人将经历慢性疼痛”,这再次强调了推广电疗等可及治疗技术的紧迫性。
合格復健专业的持续短缺严重阻碍了全球电疗系统市场的商业性成长。熟练劳动力的短缺限制了物理治疗诊所和復健中心的运作能力,而这些诊所和復健中心正是这些医疗设备的主要购买者。由于电疗操作需要持证人员来确保安全性和有效性,人员短缺使得医疗机构无法扩展服务或增加病患数量。因此,由于人员限制导致现有设施无法充分利用,诊所投资购买新的或额外的电疗设备的经济动力也显着降低。
近期产业数据显示,这项营运瓶颈问题十分严重。美国物理治疗协会 (APTA) 发布的《2025 年劳动力调查》显示,约 72% 的物理治疗师面临人手不足、无法满足当地需求或只能勉强维持工作。这项数据凸显了日益增长的疼痛管理临床需求与实际医疗服务供应之间存在的巨大差距。由于医疗机构在人手不足的情况下难以应对现有患者数量,对新设备的需求仍然低迷,直接阻碍了市场的整体成长。
远端患者监护(RPM) 和远端医疗功能的整合正在改变市场格局,将临床监管与家庭护理结合。与传统的携带式设备不同,现代电疗系统具备无线数据同步功能,使医护人员无需前往诊所即可即时监测患者的使用模式、调整刺激设定并追踪其依从性。这种互联互通有效地缓解了復健人员短缺造成的营运限制,使诊所能够在保证治疗品质的同时,高效处理更多病例。 Zynex 公司就是一个例证,凸显了这些互联解决方案的商业性可行性。该公司在 2025 年 3 月发布的「2024 财年第四季及全年业绩报告」中指出,2024 财年全年订单增 16%,这主要得益于支持分散式护理的处方笺管理设备的广泛应用。
同时,神经肌肉电刺激(NMES)在运动医学领域的应用日益广泛,涵盖了从损伤復健到主动恢復和运动表现优化等各个方面。运动员和健身爱好者越来越多地使用电疗来促进肌肉恢復、清除乳酸并预防运动伤害,这使得潜在市场规模从慢性疼痛患者扩展到积极健康的群体。儘管经济情势波动,但该领域仍展现出可持续性和稳定的需求,这主要得益于业余体育运动的职业化以及人们对体能训练日益增长的重视。例如,Enobis公司于2025年2月发布的「2024财年第四季及全年业绩报告」显示,其预防和復健业务板块实现了3%的同比增长,证实了这些技术在运动领域的稳步应用。
The Global Electrotherapy System Market is projected to increase from a valuation of USD 1.28 Billion in 2025 to USD 1.88 Billion by 2031, registering a CAGR of 6.62%. These medical systems employ electrical energy to stimulate nerves and muscles, facilitating pain management, neuromuscular re-education, and tissue repair. Key factors fueling this growth include the rising prevalence of chronic musculoskeletal disorders and a globally aging demographic that requires ongoing physical rehabilitation. Furthermore, the market benefits from a critical transition toward non-invasive, non-pharmacological therapies, a trend largely motivated by the urgent clinical need to reduce opioid dependence among chronic pain sufferers.
| Market Overview | |
|---|---|
| Forecast Period | 2027-2031 |
| Market Size 2025 | USD 1.28 Billion |
| Market Size 2031 | USD 1.88 Billion |
| CAGR 2026-2031 | 6.62% |
| Fastest Growing Segment | Transcutaneous Electrical Nerve Stimulation (TENS) |
| Largest Market | North America |
Despite these positive indicators, market expansion faces a substantial hurdle due to the ongoing scarcity of qualified rehabilitation professionals needed to deliver these treatments. This labor shortage constrains the operational capabilities of clinics, subsequently dampening the demand for new equipment acquisitions. Data from the American Physical Therapy Association indicates that in 2024, the national vacancy rate for outpatient physical therapy practices was 9.5%, highlighting a workforce limitation that directly curtails the accessibility and broad utilization of electrotherapy systems.
Market Driver
Technological advancements in portable and wearable electrotherapy devices serve as a major catalyst for market growth, fundamentally changing how patients access pain management. The emergence of compact, user-friendly systems enables effective self-administration of electrical stimulation in home environments, thereby decreasing the necessity for frequent clinical appointments. This transition toward home-based healthcare is evidenced by strong commercial demand for next-generation systems; for instance, Zynex, Inc. reported a 13% year-over-year rise in device orders in its "Third Quarter 2024 Financial Results" released in October 2024, signaling robust interest in prescription-strength, non-invasive solutions. Such innovations not only improve patient convenience but also promote consistent therapeutic adherence, a vital component of long-term rehabilitation success.
The escalating incidence of chronic pain and musculoskeletal conditions further drives the adoption of electrotherapy as a primary non-pharmacological treatment option. With the global burden of degenerative diseases and lifestyle-related issues rising, healthcare providers are increasingly favoring opioid-free interventions to minimize addiction risks while managing persistent pain. According to the "Chronic Pain and High-impact Chronic Pain in U.S. Adults, 2023" report published by the CDC in November 2024, roughly 24.3% of adults suffered from chronic pain, illustrating the massive scale of patients needing effective management plans. This growing clinical necessity is reflected globally, with the International Association for the Study of Pain noting in 2024 that one in five individuals worldwide experiences chronic pain, reinforcing the urgent need for accessible therapeutic technologies like electrotherapy.
Market Challenge
A continuing shortage of qualified rehabilitation professionals poses a significant obstacle to the commercial growth of the Global Electrotherapy System Market. This lack of skilled labor restricts the operational capacity of physical therapy clinics and rehabilitation centers, which are the primary purchasers of these medical devices. Because the administration of electrotherapy demands licensed personnel to guarantee safety and efficacy, staffing shortages prevent facilities from expanding their services or increasing patient volume. As a result, the financial motivation for clinics to invest in new or additional electrotherapy units is greatly reduced, as staffing limitations prevent the full utilization of existing assets.
Recent industry data underscores the severity of this operational bottleneck. A 2025 workforce survey by the American Physical Therapy Association revealed that approximately 72% of physical therapists were either facing a shortage in capacity to meet local demand or were working at the absolute limit of their professional capabilities. This statistic highlights a critical gap between the escalating clinical requirement for pain management and the actual provision of care. As providers struggle to handle existing patient loads with insufficient staff, the demand for new equipment installations remains repressed, directly inhibiting the market's broader growth trajectory.
Market Trends
The integration of Remote Patient Monitoring (RPM) and telehealth features is transforming the market by connecting clinical oversight with home-based treatment. Unlike traditional portable units, modern electrotherapy systems offer wireless data synchronization, allowing practitioners to monitor usage patterns, modify stimulation settings, and track patient compliance in real-time without physical visits. This connectivity effectively mitigates the operational constraints caused by the rehabilitation workforce shortage, enabling clinics to handle larger caseloads efficiently while maintaining therapeutic quality. The commercial viability of these connected solutions is highlighted by Zynex, Inc., which reported in its "Fourth Quarter and Full Year 2024 Financial Results" in March 2025 that full-year 2024 orders rose by 16% year-over-year, largely due to the uptake of prescription monitoring devices supporting decentralized care.
Simultaneously, the application of Neuromuscular Electrical Stimulation (NMES) is expanding within sports medicine, moving beyond injury rehabilitation to include active recovery and performance optimization. Athletes and fitness enthusiasts are increasingly utilizing electrotherapy to hasten muscle recovery, clear lactic acid, and prevent injuries, thereby extending the total addressable market from chronic pain patients to the active, healthy population. This segment has shown durability and consistent demand despite economic variables, driven by the professionalization of amateur sports and a focus on physical conditioning. For example, Enovis Corporation's "Fourth Quarter and Full Year 2024 Results" from February 2025 noted that its Prevention and Recovery segment achieved a 3% year-over-year comparable sales growth, confirming the steady adoption of these technologies in the athletic sector.
Report Scope
In this report, the Global Electrotherapy System Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Company Profiles: Detailed analysis of the major companies present in the Global Electrotherapy System Market.
Global Electrotherapy System Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report: